# Latent **Source:** https://geo.sig.ai/brands/latent **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** latent.health **Last Updated:** 2026-04-14 ## Summary Healthcare AI automating prior authorization documentation by reviewing patient records; $13.1M from General Catalyst and YC achieving $2.4M revenue competing with Cohere Health for pharmacy workflow automation. ## Company Overview Latent is a San Francisco-based healthcare AI company automating clinical operations for pharmacy and medication access workflows — using AI to review patient medical records, generate evidence-based prior authorization documentation, and streamline the clinical justification process that currently requires pharmacists and clinical staff to spend significant time on administrative documentation that delays patients' access to medications. Founded in 2022 and a Y Combinator W23 graduate, Latent raised $13.1 million from General Catalyst and Y Combinator, achieving $2.4 million in revenue in 2024. Latent's AI reads patient clinical records (diagnoses, labs, prior medication history, physician notes) and generates the clinical evidence summaries and prior authorization submissions that insurance companies require before approving specialty medications. Prior authorization — the process where physicians must justify to insurance companies why a specific (often expensive) medication is medically necessary — has become one of the most administratively burdensome aspects of healthcare, with studies showing physicians spend 2+ hours per day on prior auth requests for their patient panels. In 2025, Latent competes in the prior authorization automation and healthcare AI market with Cohere Health (prior auth automation, raised $150M+), Waystar (revenue cycle, acquired Olive AI's prior auth business), Availity, and physician practice management platforms for prior authorization and clinical documentation automation. The AMA's annual survey consistently shows prior authorization as physicians' top administrative burden, and multiple legislative efforts (including CMS prior authorization rules taking effect in 2026) are attempting to streamline the process. AI automation that handles the record review and documentation generation can reduce this burden while actually improving approval rates — AI systems that correctly identify and present clinical evidence get approvals that manual submissions miss. General Catalyst's backing is strategically significant in healthcare AI. The 2025 strategy focuses on pharmacy benefit management integration, specialty medication focus (oncology, biologics) where prior auth burden is highest, and health system enterprise deployments. ## Frequently Asked Questions ### What is Latent? Latent is a healthcare AI company founded in 2022 that builds medical language models to automate healthcare operations. The company uses clinical AI to review full patient records and generate evidence-based documentation, reducing operational costs for healthcare providers. ### What products and services does Latent offer? Latent offers medical language models and clinical AI solutions that review full patient records, generate evidence-based documentation, and manage pharmacy-related workflows. Their platform helps healthcare providers automate clinical documentation and operational tasks with greater accuracy and speed. ### Who are Latent's target customers? Latent targets healthcare providers, with a focus on organizations seeking operational automation and clinical documentation efficiency. Their solutions are designed for healthcare facilities that manage pharmacy workflows and patient record processing. ### When was Latent founded? Latent was founded in 2022 by Rishabh Jain and Sri Somasundaram. The company participated in Y Combinator's Winter 2023 batch. ### Where is Latent located? Latent is based in San Francisco, California, USA. ### How much funding has Latent raised? Latent has raised $13.1M in total funding from investors including Conviction Partners, General Catalyst, Y Combinator, and Avra. ### What are Latent's key achievements and metrics? Latent achieved $2.4M in revenue in 2024 and currently has 16-30 employees. The company has raised $13.1M in total funding and successfully completed Y Combinator's Winter 2023 program. ### What technology approach does Latent use? Latent uses medical language models and clinical AI technology to review full patient records and generate evidence-based documentation. Their AI-powered platform automates healthcare operations with a focus on accuracy and speed. ### How does Latent help patients and healthcare providers? Latent's platform enables patients to get life-saving medications faster by managing pharmacy-related workflows with greater accuracy and speed. The company reduces operational costs for healthcare providers through automated clinical documentation and patient record review. ### What are Latent's recent developments? Latent recently raised $13.1M in total funding from Conviction Partners, General Catalyst, Y Combinator, and Avra, and achieved $2.4M in revenue in 2024. The company has grown to 16-30 employees while continuing to develop its medical language models and clinical AI platform. ## Tags healthtech, enterprise, north-america, b2b --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*